These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8992026)

  • 1. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and residues in milk of oxytetracyclines administered parenterally to dairy goats.
    Rule R; Moreno L; Serrano JM; Roman AG; Moyano R; Garcia J
    Aust Vet J; 2001 Jul; 79(7):492-6. PubMed ID: 11549049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    El Korchi G; Prats C; Arboix M; Pérez B
    J Vet Pharmacol Ther; 2001 Aug; 24(4):247-50. PubMed ID: 11555179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pharmacokinetics and tissue and milk residues of oxytetracycline in goats following a single intramuscular injection of a long-acting preparation and milk residues following a single subcutaneous injection.
    Payne MA; Babish JG; Bulgin M; Lane M; Wetzlich S; Craigmill AL
    J Vet Pharmacol Ther; 2002 Feb; 25(1):25-32. PubMed ID: 11874523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.
    Kumar R; Malik JK
    Vet Res Commun; 1998 Dec; 22(8):533-44. PubMed ID: 10066127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    Lees P; Gettinby G; Toutain PL
    J Vet Pharmacol Ther; 2002 Jun; 25(3):237-8. PubMed ID: 12081620
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of Short- and Long-acting Formulations of Oxytetracycline After Intramuscular Administration in Chickens.
    Gberindyer AF; Okpeh ER; Semaka AA
    J Avian Med Surg; 2015 Dec; 29(4):298-302. PubMed ID: 26771319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and local tolerance of a long-acting oxytetracycline formulation in camels.
    Oukessou M; Uccelli-Thomas V; Toutain PL
    Am J Vet Res; 1992 Sep; 53(9):1658-62. PubMed ID: 1416372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of oxytetracycline in swine after administration of the drug intramuscularly and orally in feed.
    Hall WF; Kniffen TS; Bane DP; Bevill RF; Koritz GD
    J Am Vet Med Assoc; 1989 May; 194(9):1265-8. PubMed ID: 2722658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between oral fluid and plasma oxytetracycline concentrations after intramuscular administration in pigs.
    Gajda A; Jablonski A; Gbylik-Sikorska M; Posyniak A
    J Vet Pharmacol Ther; 2017 Dec; 40(6):e39-e44. PubMed ID: 28456999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma bioavailability of 2 long-acting oxytetracycline formulations in the pig.
    Archimbault P; Navetat H; Vidal R; Douin MJ; Mignot A
    Vet Res; 1994; 25(4):399-404. PubMed ID: 8087147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on irritation and residue aspects of five oxytetracycline formulations administered intramuscularly to calves, pigs and sheep.
    Nouws JF; Smulders A; Rappalini M
    Vet Q; 1990 Jul; 12(3):129-38. PubMed ID: 2219655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the serum pharmacokinetics of a long acting and a conventional oxytetracycline injection.
    Davey LA; Ferber MT; Kaye B
    Vet Rec; 1985 Oct; 117(17):426-9. PubMed ID: 4071932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic disposition of a long-acting oxytetracycline formulation after single-dose intravenous and intramuscular administrations in the American alligator (Alligator mississippiensis).
    Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
    J Zoo Wildl Med; 2004 Sep; 35(3):341-6. PubMed ID: 15526889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of a long-acting oxytetracycline formulation in healthy dogs and in dogs infected with Ehrlichia canis.
    Kikuvi GM; Mitema ES; Buoro IB
    Vet Res Commun; 2001 Jul; 25(5):391-400. PubMed ID: 11469510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oxytetracycline in goats: modifications induced by a long-acting formulation.
    Escudero E; Carceles CM; Serrano JM
    Vet Rec; 1994 Dec; 135(23):548-52. PubMed ID: 7886888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum oxytetracycline concentrations in African elephant (Loxodonta africana) calves after long-acting formulation injection.
    Bush M; Stoskopf MK; Raath JP; Papich MG
    J Zoo Wildl Med; 2000 Mar; 31(1):41-6. PubMed ID: 10884122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritation, bioavailability, and residue aspects of ten oxytetracycline formulations administered intramuscularly to pigs.
    Nouws JF
    Vet Q; 1984 Apr; 6(2):80-4. PubMed ID: 6740894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of a long-acting oxytetracycline formulation in Thai swamp buffaloes (Bubalus bubalis).
    Poapolathep S; Wongpanit K; Imsilp K; Tanhan P; Klangkaew N; Giorgi M; Poapolathep A
    J Vet Pharmacol Ther; 2017 Apr; 40(2):206-209. PubMed ID: 27597645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.